- ログイン
- 今すぐ認証
- 取引
- 受取金額
| 時間 | 最安値 | 最高価格 | %Chg |
|---|---|---|---|
| 過去7日間 | -- | -- | -- |
| 過去30日間 | -- | -- | -- |
| 過去90日間 | -- | -- | -- |
| 1年 | -- | -- | -- |
| 過去 | -- | -- | -- |
Vaxcyte is a clinical-stage vaccine company that uses technologies such as cell-free protein synthesis to develop vaccines. Its lead candidates include VAX-31 and VAX-24, both designed to prevent invasive pneumococcal disease.

